Exploring Novel Recombinant Human Alpha- Fetoprotein Conjugate for Effective & Safe Targeting of Cancers & Myeloid-Derived Suppressor Cells
Time: 2:30 pm
day: Conference Day One - Track 1 - PM
Details:
- Delving into the use of novel, highly effective and safe protein-drug conjugates
- Describing how the AFP receptor is a unique target present exclusively on cancer and MDSC cells
- Highlighting how natural human proteins have been shownto be exceptionally safe in clinical trials and can be used to target AFP receptors
